BHCC(600800)

Search documents
渤海化学(600800.SH):拟公开挂牌转让解放南路325号房产及附属物
Ge Long Hui A P P· 2025-09-12 08:21
格隆汇9月12日丨渤海化学(600800.SH)公布,公司拟将所拥有的位于天津市河西区解放南路325号房产 及附属物以公开挂牌的方式进行转让,挂牌价格不低于人民币1.37亿元,最终交易金额以实际成交价格 为准。 本次作价是在综合参考工业房产评估值的基础上,再充分考虑该房产未来商业价值、现阶段建筑改造升 值空间以及长期稳定的租金收益等因素,在合理数值范围内溢价定价。实际转让价格以最终挂牌交易价 格为准。 ...
渤海化学拟挂牌转让解放南路325号房产及附属物
Zhi Tong Cai Jing· 2025-09-12 08:18
本次交易是为聚焦公司主业发展,降低公司运营成本,盘活闲置资产,提升资产使用效率,符合公司战 略发展需要。根据挂牌价格预测,若公司能按照挂牌价格处置上述资产,公司将产生利润总额9,000万 元,但因本次资产处置存在不确定性,具体金额以处置完成后会计师事务所出具的年度审计报告为准。 渤海化学(600800)(600800.SH)发布公告,公司为满足整体战略规划与经营效益提升的需求,盘活公 司闲置资产,提高资产运营效率,现拟将公司所属的天津市河西区解放南路325号房产及附属物以不低 于1.37亿元的价格进行公开挂牌转让。根据国众联资产评估土地房地产估价有限公司出具的《资产评估 报告》(国众联评报字(2025)第3-0141号),评估基准日2025年3月31日账面价值2,723.45万元,评估价值 6,645.44万元,增值率144.01%。 ...
渤海化学(600800.SH)拟挂牌转让解放南路325号房产及附属物
智通财经网· 2025-09-12 08:12
智通财经APP讯,渤海化学(600800.SH)发布公告,公司为满足整体战略规划与经营效益提升的需求, 盘活公司闲置资产,提高资产运营效率,现拟将公司所属的天津市河西区解放南路325号房产及附属物 以不低于1.37亿元的价格进行公开挂牌转让。根据国众联资产评估土地房地产估价有限公司出具的《资 产评估报告》(国众联评报字(2025)第3-0141号),评估基准日2025年3月31日账面价值2,723.45万元,评 估价值6,645.44万元,增值率144.01%。 本次交易是为聚焦公司主业发展,降低公司运营成本,盘活闲置资产,提升资产使用效率,符合公司战 略发展需要。根据挂牌价格预测,若公司能按照挂牌价格处置上述资产,公司将产生利润总额9,000万 元,但因本次资产处置存在不确定性,具体金额以处置完成后会计师事务所出具的年度审计报告为准。 ...
渤海化学(600800) - 天津渤海化学股份有限公司关于参加“天津辖区上市公司2025年投资者网上集体接待日暨半年报业绩说明会”的公告
2025-09-01 08:15
证券代码:600800 证券简称:渤海化学 编号:临 2025-042 天津渤海化学股份有限公司 一、会议主题 天津渤海化学股份有限公司(以下简称"公司")为进一步加强 与投资者的沟通交流,公司定于 2025 年 9 月 11 日(周四)下午 15:00-17:00 期间参加由天津证监局主办、天津上市公司协会与深圳 市全景网络有限公司共同协办的"2025 年投资者网上集体接待日暨 半年报业绩说明会"活动。本次活动将采用网络远程的方式举行,投 资者可登录"全景路演"网站(http://rs.p5w.net);或关注微信公 众号(名称:全景财经);或下载全景路演 APP,参与本次互动交流。 二、召开时间和方式 会议召开时间:2025 年 9 月 11 日(周四)下午 15:00-17:00 会议召开地点:全景路演(http://rs.p5w.net) 会议召开方式:网络互动交流 三、出席会议人员 关于参加"天津辖区上市公司 2025 年投资者网上集体接待 日暨半年报业绩说明会"的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 ...
每周股票复盘:渤海化学(600800)中报净亏3.59亿
Sou Hu Cai Jing· 2025-08-30 23:21
Core Viewpoint - Bohai Chemical's stock price has decreased by 8.97% over the past week, with a current market capitalization of 4.16 yuan and a total market value of 4.618 billion yuan [1] Group 1: Stockholder Changes - As of June 30, 2025, the number of shareholders for Bohai Chemical is 51,500, a decrease of 5,464 shareholders or 9.59% compared to March 31, 2025 [2] Group 2: Performance Disclosure Highlights - Bohai Chemical's mid-year report for 2025 shows a main revenue of 1.961 billion yuan, a year-on-year decrease of 21.73% - The net profit attributable to shareholders is -359 million yuan, down 13.68% year-on-year - The second quarter alone reported a main revenue of 1.122 billion yuan, a decline of 6.46% year-on-year, with a net profit of -190 million yuan, down 37.38% year-on-year - The company's debt ratio stands at 65.01%, with a gross profit margin of -9.24% and financial expenses of 25.37 million yuan [3][6] Group 3: Company Announcements Summary - Bohai Chemical will not distribute profits or increase capital reserves for the first half of 2025 - The board has approved the half-year report and related financial assessments - Tianjin Bohai Group Financial Co., Ltd. reported total assets of 7.156 billion yuan and total liabilities of 5.284 billion yuan as of June 30, 2025 - The company raised a total of approximately 706 million yuan through a non-public offering, with a remaining balance of about 257 million yuan for new material projects due to previous project overcapacity [4][6]
渤海化学2025年中报简析:净利润同比下降13.68%,短期债务压力上升
Zheng Quan Zhi Xing· 2025-08-27 22:56
Core Insights - Bohai Chemical (600800) reported a significant decline in financial performance for the first half of 2025, with total revenue of 1.961 billion yuan, down 21.73% year-on-year, and a net loss attributable to shareholders of 359 million yuan, a decrease of 13.68% compared to the previous year [1] Financial Performance Summary - Total revenue for the second quarter was 1.122 billion yuan, reflecting a year-on-year decrease of 6.46% [1] - The company's gross margin was -9.24%, down 12.23% year-on-year, while the net margin fell to -18.29%, a decline of 45.25% [1] - Total expenses (selling, administrative, and financial) amounted to 89.03 million yuan, representing 4.54% of revenue, an increase of 43.46% year-on-year [1] - Earnings per share decreased to -0.32 yuan, down 14.29% year-on-year, and operating cash flow per share was -0.37 yuan, a drastic decline of 447.27% [1] Balance Sheet Analysis - Cash and cash equivalents decreased by 60.64% to 509 million yuan due to increased funding needs for production recovery [3] - Short-term borrowings increased by 41.93% to 1.858 billion yuan, indicating rising debt pressure [11] - The current ratio stood at 0.73, highlighting liquidity concerns [1] Operational Insights - Accounts receivable decreased by 11.23% to 59.13 million yuan, while inventory surged by 141.07% due to increased raw material and finished goods requirements [4][7] - The company experienced a 21.73% decline in operating income, attributed to decreased production and sales [19] - Research and development expenses fell by 17.71%, indicating reduced investment in innovation [23] Cash Flow and Investment Activities - Net cash flow from operating activities plummeted by 447.27%, primarily due to reduced income from sales [24] - Cash flow from investment activities decreased significantly by 1168.73%, driven by increased investment in fundraising projects [25] - Cash flow from financing activities rose by 35.8%, reflecting an increase in borrowings [26] Historical Performance Context - The company's historical financial performance has been weak, with a median Return on Invested Capital (ROIC) of 2.56% over the past decade, and 11 years of losses since its listing [27] - The business model relies heavily on R&D and capital expenditures, necessitating careful scrutiny of the viability of these investments [27]
渤海化学:8月26日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-26 23:09
Group 1 - Bohai Chemical announced the convening of its 17th meeting of the 10th board of directors on August 26, 2025, to review the 2025 semi-annual report and summary [1] - For the year 2024, Bohai Chemical's revenue composition is as follows: Chemicals account for 98.5%, magnetic cards for 0.92%, printing industry for 0.34%, machinery products for 0.23%, and other businesses for 0.01% [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to a surge in stock prices for industry-listed companies [1]
渤海化学: 天津渤海化学股份有限公司关于天津渤海集团财务有限责任公司风险持续评估报告
Zheng Quan Zhi Xing· 2025-08-26 16:19
Core Viewpoint - Tianjin Bohai Chemical Co., Ltd. conducted a risk assessment report on Tianjin Bohai Group Financial Co., Ltd., confirming its compliance with regulatory requirements and evaluating its operational and risk management capabilities [1][16]. Group 1: Company Overview - Tianjin Bohai Group Financial Co., Ltd. was established on November 4, 1992, as a non-bank financial institution, being the first enterprise group financial company in Tianjin [1]. - The registered capital is 1 billion RMB, with a planned increase to 1.5 billion RMB following approval from the Tianjin Financial Regulatory Bureau [1]. - The company has various membership qualifications, including participation in the national interbank lending center and other financial associations [1]. Group 2: Business Scope - The financial company’s business includes accepting deposits from member units, providing loans, bill discounting, bill acceptance, fund settlement, and various financial advisory services [1]. Group 3: Internal Control and Risk Management - The financial company has established a comprehensive risk management system covering market, credit, operational, liquidity, compliance, and reputational risks [2][3]. - Daily risk monitoring focuses on key indicators such as capital adequacy ratio, liquidity ratio, and non-performing asset ratio [3]. - The governance structure includes a board of directors, supervisory board, and senior management, ensuring effective oversight and compliance [3]. Group 4: Financial Performance - As of June 30, 2025, the total assets of the financial company reached 7.156 billion RMB, a 24.55% increase from the previous year [14]. - The total liabilities amounted to 5.284 billion RMB, reflecting a 25.10% growth year-on-year [14]. - The company achieved an operating income of 84.2315 million RMB in the first half of 2025, meeting 49.32% of its annual budget target [14]. Group 5: Regulatory Compliance - The financial company adheres to the regulations set forth by the China Banking and Insurance Regulatory Commission, with all supervisory indicators within acceptable limits [15][16]. - The company has not identified any significant deficiencies in its risk management framework since its establishment [16].
渤海化学: 天津渤海化学股份有限公司关于2025年1-6月募集资金实际存放与使用情况的专项报告
Zheng Quan Zhi Xing· 2025-08-26 16:19
公司于 2025 年 4 月 28 日召开第十届董事会第十四次会议、第十届监事会第十四次会议, 分别审议通过《关于使用部分闲置募集资金进行现金管理的议案》,独立财务顾问发表了同 意意见,公司使用不超过人民币 35,000 万元的闲置募集资金进行现金管理,该额度自公司 董事会审议通过该议案之日起不超过 12 个月,可循环滚动使用。 公司本报告期内未发生闲置募集资金现金管理活动。 证券代码:600800 证券简称:渤海化学 编号:临 2025-040 天津渤海化学股份有限公司 关于 2025 年 1-6 月募集资金实际存放与使用情况的 专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 天津渤海化学股份有限公司(以下简称"本公司")董事会根据《上海证券交易所股票 上市规则》 《上海证券交易所上市公司自律监管指引第 1 号——规范运作》 《上市公司募集资 金监管规则》等相关法律法规的要求及公司章程的规定,编制了本公司截至 2025 年 6 月 30 日止的募集资金使用情况的专项报告(以下简称"募集资金使用情况专项报告" )。 ...
渤海化学: 渤海化学:大信会计师事务所(特殊普通合伙)关于天津渤海化学股份有限公司2025年1-6月募集资金存放与实际使用情况审核报告
Zheng Quan Zhi Xing· 2025-08-26 16:19
Core Viewpoint - The report provides an audit of Tianjin Bohai Chemical Co., Ltd.'s fundraising activities and the actual use of raised funds for the first half of 2025, confirming compliance with regulations and accurate reporting of fund usage [1][2]. Fundraising Overview - The company raised a total of RMB 706,018,058.90 through a non-public offering of 183,381,314 shares at RMB 3.85 per share, with net proceeds amounting to RMB 69,895.79 million after deducting issuance costs [2][3]. - The funds are managed under a specific management plan to ensure proper usage and efficiency, with dedicated accounts for storage [2][3]. Fund Storage and Usage - As of June 30, 2025, the total balance of the raised funds was RMB 25,677.51 million after accounting for various expenditures, including RMB 20,000 million temporarily used for working capital and RMB 28,154.60 million invested in projects [2][3]. - The company has established a four-party supervision agreement for the management of the raised funds, ensuring compliance with regulatory requirements [2][3]. Project Investment and Changes - The company has changed the investment focus from the "Propane Dehydrogenation Unit Technical Transformation Project" to the "Acrylic Ester and Super Absorbent Resin New Material Project" due to market conditions affecting the feasibility of the original project [2][3][5]. - The new project is currently being implemented as planned, with no significant changes in feasibility reported [5][6]. Idle Fund Management - The company has not engaged in cash management activities for idle funds during the reporting period, and no permanent use of excess funds for working capital or loan repayment has occurred [4][6]. - A temporary use of up to RMB 20,000 million of idle funds for working capital was approved, with a commitment to return the funds to the dedicated account as needed [4][6].